COVID-19 and its impact on clinical trials
Featuring Sheila Diamond, Scientific Business Development at Acorn AI-Medidata
Abstract: 'COVID-19 and its impact on clinical trials'.
As COVID-19 has spread, we see the profound impact on our industry, both at a global and site level. Delays are being seen in the start of new studies, as well as in enrollments in ongoing studies, and patients already enrolled are facing challenges making their scheduled visits. This session will demonstrate the value of performance analytics depicting standardized views across geographies and therapeutic areas to monitor and respond to the COVID-19 impact, giving an overall view of the temporal aspect of how the industry has progressed. Sharing these data analyses and industry insights are key in understanding COVID-19's impact on a global level in order to fuel public health action.